Global President, I&I, Pfizer
Angela Hwang is the Global President of Pfizer Inflammation & Immunology. In this role, Angela leads an extensive multi-functional global, regional and country based organization focused on developing, launching and driving revenue for products in rheumatology, gastroenterology and dermatology.
Angela joined Pfizer in 1997 and over the last 20 years, she has held 10 different positions in the company spanning areas in strategy, product development, marketing, sales and general management. Her experience covers a large array of therapeutic areas, including CV/Met, CNS/Pain, Urology/Women’s Health, Vaccines and Inflammation and Immunology, geographical breadth (U.S. and international markets), and assets in all stages of their lifecycle.
Angela has built a strong track record of company and industry impact. In her role as Regional President for US Vaccines (2014 – 2015), she activated the market for adult pneumococcal vaccines, driving a record number of adults being vaccinated within the first year of the full commercialization of Prevnar 13. In her role as Vice President and Head of Primary Care for the Emerging Markets (2011-2013), she invigorated a portfolio of launch and mature products to growth through market and access development and targeted customer strategies. And in her role as Vice President US Established Products (2009 – 2011), she pioneered Pfizer’s strategy to maximize product value post loss of exclusivity and launched a plan for Lipitor, Pfizer’s most iconic brand, that continued to generate patient loyalty and value to Pfizer for years after Lipitor lost its patent. She has also been an active participant in industry groups such as BIO where she co-chaired the Vaccines Policy Committee for 2 years.
Prior to joining Pfizer, Angela worked at the Wilkerson Group in New York, a health care strategy consulting firm. And before that, she was a research microbiologist for the South African Breweries based in Johannesburg, South Africa. A native of South Africa, Angela received her Bachelor of Science in Microbiology and Biochemistry from the University of Cape Town and her MBA from Cornell University.